1. Familial hypercholesterolaemia is a common genetic abnormality in man characterized by premature atherogenesis as a consequence of disturbed lipoprotein metabolism. Chylomicrons, which represent intestinally derived lipoproteins, are cleared poorly in familial hypercholesterolaemia which may explain the increased retention of chylomicron remnants in arterial fatty lesions. However, cellular uptake of chylomicron remnants in familial hypercholesterolaemia remains unclear. This study determined the quantitative significance of non-lowdensity lipoprotein receptor-mediated uptake in fibroblasts from subjects with homozygous familial hypercholesterolaemia. 2. The metabolism of chylomicron remnants was assessed in fibroblasts from subjects with homozygous familial hypercholesterolaemia who lack low-density lipoprotein receptors. Compared with fibroblasts from normolipidaemic subjects, binding and degradation of chylomicron remnants was reduced by about two-thirds. Nevertheless, degradation of chylomicron remnants in cells from subjects with familial hypercholesterolaemia persisted in the absence of functioning low-density lipoprotein receptors. 3. Binding of chylomicron remnants to fibroblasts from subjects with familial hypercholesterolaemia was saturable. Unlabelled chylomicron remnants competed efficiently for binding but unlabelled low-density lipoprotein or a monoclonal antibody specific to the human low-density lipoprotein receptor had little effect on binding or degradation. 4 . Polyinosinic acid did not alter binding and degradation of chylomicron remnants by fibroblasts from subjects with familial hypercholesterolaemia, ruling out involvement of the scavenger receptor. Lactoferrin was found to inhibit binding and degradation of chylomicron remnants by fibroblasts from subjects with familial hypercholesterolaemia by approximately SO%, implicating involvement of the az-macroglobulin receptor. 5. Cytochalasin D blocked degradation of chylomicron remnants at 37°C in fibroblasts from subjects with familial hypercholesterolaemia by more than 80% but had no effect on binding at 4"C, consistent with a phagocytic uptake pathway. Collectively, the data suggest that chylomicron remnants bind to a cell-surface protein which initiates phagocytosis and that lactoferrin interferes with binding to this putative cell-surface protein. Phagocytic uptake of chylomicron remnants provides an additional mechanism whereby cells from subjects with familial hypercholesterolaemia can accumulate lipid.
INTRODUCTION
Familial hypercholesterolaemia (FH) is a genetically inherited disorder which affects approximately 0.2% of the population. An increase in plasma low-density lipoprotein (LDL) in FH is due to a mutation in the LDL receptor gene which leads to decreased expression of functional LDL receptors (apolipoprotein Bloo/E receptors) [l] . In the absence of the LDL receptor, the increased plasma concentration of lipoproteins which utilize this pathway results in increased arterial deposition of lipoprotein cholesterol and premature atherogenesis.
The role of the LDL receptor in clearance of LDL is well established. Less clear is the significance of the LDL receptor in the clearance of chylomicron remnants. Chylomicron remnants are the post-hydrolytic product of intestinally derived chylomicrons, which are responsible for the transport of dietary lipid [2] . Rubinsztein et al. [3] assessed chylomicron remnant kinetics in subjects with FH phenotype but found no evidence of a defect in clearance. In contrast, others have suggested that clearance is significantly slower in subjects with FH [4] or familial combined hyperlipidaemia [5] . Studies in animal models of FH are also contradictory. Kita et al. [6] found no defect in plasma clearance of chylomicron remnants in homozygote Watanabe heritable-hyperlipidaemic (WHHL) rabbits, but several studies have since found significant impairment in clearance of chylomicron remnants in WHHL rabbits [7, 81 . In knockout mice lacking LDL receptors, plasma chylomicron remnant clearance was unaffected; however, hepatic endocytosis was severely delayed which was consistent with a role of the receptor in particle clearance [9] . Overall, a number of different studies have concluded that, in vivo, the LDL receptor is the primary high-affinity mechanism by which chylomicron remnants are cleared [7, 101. In subjects with FH, the activity of non-LDL receptor pathways may be critical to the rate of atherogenesis. Non-LDL receptor binding sites for chylomicron remnants include the LDL receptorrelated protein (LRP) [ll-141, the asialoglycoprotein receptor [15] and the lipolysis-stimulated receptor [16] . Recently, we reported a novel mechanism whereby macrophages exhibited rapid degradation of chylomicron remnants via a phagocytic pathway [17] . To explore whether phagocytosis of chylomicron remnants could contribute to non-LDL receptor-mediated clearance, we investigated whether the phagocytic response was also a property of other cells. This study reports on the quantitative significance of phagocytic degradation of chylomicron remnants by cultured human skin fibroblasts from subjects with homozygous FH.
MATERIALS AND METHODS

Materials
Dulbecco's modified Eagle's medium with glutamine (DMEM), fetal bovine serum (FBS), penicillin, streptomycin and amphotericin were purchased from GIBCO BRL. Tissue cultureware was from Falcon (Becton Dickinson, NJ, U.S.A.). Sodium [1251]iodide was purchased from Australian Nuclear Science and Technology Organisation (New South Wales, Australia). BSA was purchased from Sigma. Anti-human LDL receptor IgG (C7) (catalogue code RPN 537) was purchased from Amersham (Australia). All other chemicals used were purchased from Ajax Chemicals (Australia) and were of analytical grade.
Preparation of chylomicron remnants and LDL
Human LDL (density = 1.019-1.063 g/ml) was isolated from human plasma of fasted normolipidaemic subjects. Nascent chylomicrons were obtained from lymph-cannulated donor Wistar rats [7] . Chylomicron remnants were prepared by injecting chylomicrons (0.5 g of triacylglycerolkg of body weight) via the femoral vein into functionally hepatectomized rabbits (4-5 kg) and leaving to circulate for 3 h [17] . A large dose of triacylglycerol (about 20 times the normal plasma pool) was chosen to dilute residual very-low-density lipoproteins. The remnants (density -= 1.006 g/ml) were isolated from rabbit plasma by ultracentrifugation [18] . SDS/ PAGE showed an apolipoprotein profile consistent with chylomicron remnants. The apolipoprotein A-I:B~B:C:E ratio was 7 : 16 : 18 : 52 (%) based on densitometric scanning of the remnant proteins separated by SDS/PAGE with no detectable albumin. Lipoprotein size was determined using an automated laser beam particle sizer (Brookhaven Industries Pty. Ltd) and confirmed by electron microscopy. Chylomicron remnants had a diameter of 40-47 nm and a triacylglycerol to total cholesterol ratio of less than 3.
Lipoproteins were radioiodinated using a modified tyramine cellobiose (TC) procedure to avoid exposure to oxidizing agents. Briefly, TC was radioiodinated in the presence of iodogen (Pierce, IL, U.S.A.). After removal of the oxidizing agent, the radioiodinated TC was activated with cyanuric chloride and incubated with lipoproteins for 1 h. Unbound radioiodinated TC was separated from the lipoprotein fractions by elution through acrylamide columns (Econo-Pac 10DG; BioRad Australia Pty. Ltd) with 0.1 mol/l NH4HC03. Radiolabelled lipoproteins were dialysed against NH4HC03 for up to 1 h followed by extensive dialysis with PBS. Over 90% of the 1251 radioactivity on chylomicron remnants was precipitated by 20% (wt/vol.) trichloroacetic acid, and less than 10% of the 1251 radioactivity was extractable into chloroform/methanol. The radioactivity on apolipoproteins B (56%), Es and Cs (44% combined) does not alter the kinetics of chylomicron remnants, or exchange to other lipoproteins in vivo or in vitro [19] . Specific activities of '251-TC-chylomicron remnants ranged from 137 to 362 c.p.m./ng protein. For '251-TC-labelled LDL, more than 85% of the radioactivity was precipitated by 20% trichloroacetic acid and 7% was extracted into chloroform/methanol. The distribution of the radioactivity found in the apolipoproteins was about 85% in B and 15% in Cs and Es combined. Specific activities of 1251-TC-LDL ranged from 153 to 426 c.p.m./ng protein.
Tissue culture assays
Skin biopsies were obtained from two subjects with normolipidaemia (cholesterol less than 4.5 mmol/l and triacylglycerol less than 1.5 mmol/l), aged less than 40years with no history of heart disease, and from three patients with homozygous FH. The genetic abnormality of each of the patients with FH has been described previously [20] . Fibroblasts were grown in DMEM+10% FBS. Two days I99 before each experiment, the FBS was removed and the cells were maintained in DMEM without FBS supplementation. In some experiments cells were treated with phorbol myristate acetate (PMA) at a concentration of 0.1 pg/ml for 2 h before binding and degradation experiments.
For binding and degradation experiments, cells were incubated with 1251-TC-labelled lipoproteins for 90min at 4°C or 37°C. After incubation, cells were washed once with ice-cold PBS (pH7.4) plus 1 mg/ml BSA, then twice with ice-cold PBS (pH 7.4) alone, and finally were dissolved in 0.1 mol/l NaOH. The radioactivity corresponding to the amount of 1251-TC-lipoprotein bound or taken up by the cells was counted. The lZ5I-TC label serves as a marker for intracellular degradation of the ligand as it is trapped within the cell and not excreted into the extracellular medium. Aliquots of the solubilized cells were used to measure protein content. Binding was defined as the amount of 1251-TC-lipoprotein bound at 4°C. Uptake was defined as the amount of 1251-TC-lipoprotein bound, internalized and degraded at 37°C. Specific binding and uptake of 1251-TC-lipoproteins was determined as the difference in the amount of radioactivity obtained in the presence of a 10-fold excess of the respective unlabelled lipoproteins from that obtained in their absence.
Other assays
Triacylglycerol mass was measured after correction for free glycerol using the WAKO (Japan) test kit (catalogue numbers: 430-11291, 432-11491, 436-11391). Lipoprotein-protein and cellular protein were determined using the bicinchoninic acid (BCA) test kit from Pierce (IL, U.S.A.).
RESULTS
Fibroblasts from three patients with homozygous FH (patients 1, 2 and 3) and from control subjects were incubated with 10 pg protein/ml of lZ5I-TC-chylomicron remnants or lZ5I-TC-LDL. Table 1 shows the results of chylomicron remnant and LDL binding by FH fibroblasts as the percentage of that bound by normal fibroblasts (controls) respectively. In fibroblasts of subjects with FH, chylomicron remnant binding at 4°C was, on average, one-third that of normal fibroblasts. Degradation of chylomicron remnants by FH fibroblasts at 37°C was substantially reduced compared with control subjects but degradation persisted which was consistent with alternate uptake pathways.
The binding and uptake of radioiodinated LDL was more greatly depressed than that of chylomicron remnants in fibroblasts of patients with FH. The rates of degradation were less than 10% those of fibroblasts which possessed active LDL receptors. The LDL binding and uptake activities exhibited by FH fibroblasts are consistent with those reported previously [20] . The binding and uptake of chylomicron remnants and LDL by fibroblasts of individual subjects is shown in Fig. 1 . In cells from all three patients with FH, the amount of chylomicron remnants bound exceeded that of LDL. In fibroblasts from control subjects, the total amount of chylomicron remnants or LDL bound was approximately the same. The binding and degradation of chylomicron remnants, which is represented by the cell-associated radioactivity at 37"C, was approximately five times greater than the cell-associated radioactivity at 4"C, i.e. binding to the cell membrane. However, there was variation between the different cell isolates. The degradation of chylomicron remnants, which is depicted as the difference between uptake at 37°C and amount bound at 4"C, shows that in two patients (patients 1 and 2), degradation of chylomicron remnants was significantly impaired, whereas in patient 3 the rate of chylomicron remnant degradation was only marginally reduced. The data suggest that the expression of non-LDL receptormediated chylomicron remnant pathways may vary between subjects with FH and may be regulated. For LDL, uptake at 37°C by FH fibroblasts was nine times greater than the amount bound at 4"C, but degradation in each instance was less than for chylomicron remnants and only a small fraction of control cells. In contrast to chylomicron remnants, there was little variability in degradation rates of LDL by the FH fibroblasts, suggesting that the residual uptake (compared with controls) was probably a low-affinity type. Figure 2 shows that chylomicron remnant binding and uptake in cells from subjects with FH was saturable. At 37°C the amount of cell-associated radio-activity was higher than at 4°C consistent with chylomicron remnants via phagocytosis, binding and lipopiotein internalization.
Unlabelled chylomicron remnants competed efficiently for binding and uptake of radioiodinated chylomicron remnants in FH fibroblasts (Fig. 3) . In contrast, a 20-fold excess of unlabelled LDL inhibited chylomicron remnant binding by only 20%. Unequivocal evidence that the LDL receptor was not significantly involved in chylomicron remnant degradation by FH fibroblasts is indicated by the weak effect of monoclonal antibodies against the LDL receptor, i.e. C7.
We previously reported that macrophages negative and positive for LDL receptor avidly degraded chylomicron remnants via a protein which initiated phagocytosis [17] . To establish whether cultured fibroblasts from patients with FH degraded -.
degradation studies were performed in the presence of cytochalasin D. Figure 4 (left frame) shows that at 37"C, cytochalasin D inhibited chylomicron remnant uptake in a dose-dependent manner by up to 80%. The observation that cytochalasin D had no effect on chylomicron remnant binding at 4°C is consistent with the rapid decline in phagocytic activity below 18°C. Phagocytosis is a property associated most frequently with inflammatory leucocytes. In order to explore whether degradation of chylomicron remnants by FH fibroblasts could be enhanced in the presence of mitogenic agents, cells were stimulated with PMA. FH fibroblasts treated with PMA showed a 40% increase in chylomicron remnant binding at 4°C (Fig. 5) . Moreover, uptake was enhanced by more than 150% at 37°C. Fibroblasts are known to express the scavenger receptor when stimulated by PMA [21] . To assess whether increased degradation of chylomicron remnants occurred via increased scavenger receptor expression, uptake was assessed in the presence of increasing quantities of polyinosinic acid. Figure 6 shows that polyinosinic acid had no significant effect on the binding or uptake of chylomicron remnants by activated FH fibroblasts. Rather, cytochalasin D retained its ability to suppress chylomicron remnant uptake in PMA-treated cells (Fig. 4, right frame) . In contrast to the lack of effect of scavenger receptor inhibitors, lactoferrin was found to inhibit chylomicron remnant degradation in an equipotent manner to unlabelled remnants in FH fibroblasts (Fig. 7, left frame) . The inhibitory effect was also retained in PMA-treated cells (Fig. 7, right frame) . Lactoferrin is one of the known ligands for LRP [22] ; however, LRP-mediated degradation of chylomicron remnants is thought to involve receptormediated endocytosis and not phagocytosis. Our observations raise the possibility that chylomicron remnant binding to LRP stimulates phagocytosis or, alternatively, that lactoferrin interferes with the binding of chylomicron remnants to a cell-surface protein which initiates phagocytosis.
DISCUSSION
The present study indicates that LDL receptornegative skin fibroblasts from patients with homozygous FH bind and internalize chylomicron remnants, albeit at a significantly slower rate than fibroblasts with normal LDL receptor expression. The greater amount of chylomicron remnants bound and degraded by FH fibroblasts compared with LDL suggested that the mechanism of uptake was specific or more efficient. A cell-surface protein appeared to be involved in uptake of chylomicron remnants by FH fibroblasts, because the process was saturable, and displayed high affinity. Cross-competition studies showed that LDL competed poorly for binding and uptake. Furthermore, consistent with a nominal role of the LDL receptor in degradation of remnants by FH fibroblasts was the observation that antibodies against the LDL receptor did not significantly affect remnant binding or uptake.
Recently, we reported that chylomicron remnant uptake by macrophages was achieved after binding to a cell-surface protein which initiated phagocytosis [17] . Based on competition studies, we concluded that chylomicron remnant degradation was independent of uptake via scavenger pathways or LRP. In this study, we explored the possibility that FH fibroblasts in culture could degrade chylomicron remnants via a phagocytic pathway possibly similar to that reported in macrophages. Cytochalasin D is a potent inhibitor of phagocytosis, probably after restriction of cell membrane movement. We found that cytochalasin D substantially inhibited chylomicron remnant degradation by FH fibroblasts. Alternatively, it might be that cytochalasin D competes with binding of chylomicron remnants rather than inhibiting phagocytosis, but this is unlikely as the compound had no effect at 4°C. Increased degradation did not occur via increased expression of scavenger receptors, based on the lack of inhibition by polyinosinic acid. Rather, our previous studies in macrophages have suggested that the cell-surface protein involved in remnant degradation by LDL receptor-deficient cells might be one of the complement receptors [17] . In this study, that possibility was not explored.
One key difference in the phagocytic degradation of chylomicron remnants by FH fibroblasts compared with macrophages is the observation in fibroblasts that lactoferrin inhibited the binding and uptake of chylomicron remnants in inactivated and in PMA-treated cells. In macrophages, lactoferrin and activated az-macroglobulin had no effect on binding or degradation of chylomicron remnants. There are two possible interpretations which might explain this difference. Firstly, one could conclude that in FH fibroblasts but not in macrophages, a significant amount of non-LDL receptor-mediated degradation of chylomicron remnants occurred after binding and internalization of the LRPhemnant complex. If so, then we would have to conclude that cytochalasin D interfered, indeed more efficiently than unlabelled lactoferrin, with receptor-mediated endocytosis. Such an explanation seems unlikely because in macrophages, cytochalasin D was an effective inhibitor of chylomicron remnant degradation, whereas LRP and activated az-macroglobulin were not. An alternative explanation is that lactoferrin inhibited binding of chylomicron remnants to the cell-surface protein of FH fibroblasts which triggered the phagocytic response. The latter explanation would mean that the cell membrane proteins on FH fibroblasts and macrophages triggering phagocytosis are different, or each cell type possesses a related protein which recognizes, in addition to chylomicron remnants, separate ligands. Interestingly, the complement receptors, which we have suggested might be involved in chylomicron remnant degradation via phagocytosis, are similar to scavenger receptors in that there are different isoforms [23, 241. Expression of the putative cell membrane protein which initiates phagocytosis was probably increased in the presence of PMA because binding was increased by 40% and degradation was substantially enhanced. In v i m , phagocytic degradation of chylomicron remnants by fibroblasts may be quantitatively insignificant; nevertheless, there are two important considerations which might be relevant to the pathogenesis of atherosclerosis. Firstly, this study suggests that phagocytic degradation of chylomicron remnants is a property which is not unique to scavenging leucocytes. Rather, it may be that most mammalian cells are able to phagocytose chylomicron remnants after a mitogenic or inflammatory stimulus. In fact, phagocytic uptake of chylomicron remnants may provide one explanation for lipid accumulation in intimal arterial smooth muscle cells. The second possibility raised in this study is that chylomicron remnants per se could be the triggering stimulus for expression of phagocytic binding proteins.
